68Ga-DTPA Anti-HER2 positron emission tomography/CT successfully predicts the overexpression of human epidermal growth factor receptor in lung metastases from breast cancer | Zendy

Quetzali Pitalúa-Cortés | Zendy; Francisco O. García-Pérez | Zendy; Yolanda VillaseñorNavarro | Zendy; Fernando Lara-Medina | Zendy; Juan Matus-Santos | Zendy; Irma Soldevilla-Gallardo | Zendy; Fany Iris Porras-Reyes | Zendy; Víctor M. Pérez-Sánchez | Zendy; Héctor Aquiles Maldonado-Martínez | Zendy; Wendy B. Pérez-Báez | Zendy; Isabel Sollozo-Dupont | Zendy

Open Access

⁶⁸Ga-DTPA Anti-HER2 positron emission tomography/CT successfully predicts the overexpression of human epidermal growth factor receptor in lung metastases from breast cancer

Author(s) -

Quetzali Pitalúa-Cortés,

Francisco O. García-Pérez,

Yolanda VillaseñorNavarro,

Fernando Lara-Medina,

Juan Matus-Santos,

Irma Soldevilla-Gallardo,

Fany Iris Porras-Reyes,

Víctor M. Pérez-Sánchez,

Héctor Aquiles Maldonado-Martínez,

Wendy B. Pérez-Báez,

Isabel Sollozo-Dupont

Publication year - 2017

Publication title -

bjr|case reports

Language(s) - English

Resource type - Journals

ISSN - 2055-7159

DOI - 10.1259/bjrcr.20160136

Subject(s) - positron emission tomography , epidermal growth factor receptor , human epidermal growth factor receptor 2 , breast cancer , epidermal growth factor , cancer research , lung cancer , medicine , cancer , pathology , nuclear medicine , molecular imaging , receptor , oncology , biology , in vivo , microbiology and biotechnology

Molecular identification of a metastatic tumour without the inconvenience of a biopsy and the time required for pathological characterization is possible using molecular imaging. Here, we present the case of a patient with breast cancer in whom 68 Ga-diethylenetriamine pentaacetic acid anti-human epidermal growth factor receptor 2 positron emission tomography-CT was successfully employed to characterize the expression of human epidermal growth factor receptor 2 in metastatic sites.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research